The emerging treatment of this peptide represents a major breakthrough in the handling of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets dual pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide533183.ltfblog.com/40469001/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment